Grant: CCI Applied Research and Development Grants
La Cité collégiale
$40,000.00
Optimisation of the formulation of AmacaGel for therapeutic applications
FY 2022-23
Summary
AmacaThera is a drug and cell delivery company based in Toronto developing a unique biomaterial technology - AmacaGel - for drug and cell delivery-based medical applications. The company would like to partner with the scientist of the Technology Access Center in Bio-Innovation from the college La Cité in Ottawa to deliver cell-based therapies to treat traumatic brain injury, blindness, and spinal cord injury and other high-unmet need indications using their technology. The aim of the project is to screen various excipients that can be combined with AmacaGel to support long-term cryo-storage of the cell-gel products.
Program
CCI Applied Research and Development Grants
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
CCARD-2022-00479
Name nom
Le Roy, Julien
Department département
Bureau de la recherche et de l'innovation
Organization id
28248
Institution établissement
La Cité collégiale
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2022
Competition year année de concours
2022
Award amount
40000
Program id
CCARD
Program name en
CCI Applied Research and Development Grants
Program name fr
ICC Subventions de recherche et développement appliquée
Group en
RESEARCH PARTNERSHIPS
Group fr
PARTENARIATS DE RECHERCHE
Committee code
97
Committee name en
Scholarships and Fellowships Internal Decision Committee
Committee name fr
Comité de décision interne - Bourses
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Installment
inst:1
Partie
1
Nb partie
1
Application title
Optimisation of the formulation of AmacaGel for therapeutic applications
Application summary
AmacaThera is a drug and cell delivery company based in Toronto developing a unique biomaterial technology - AmacaGel - for drug and cell delivery-based medical applications. The company would like to partner with the scientist of the Technology Access Center in Bio-Innovation from the college La Cité in Ottawa to deliver cell-based therapies to treat traumatic brain injury, blindness, and spinal cord injury and other high-unmet need indications using their technology. The aim of the project is to screen various excipients that can be combined with AmacaGel to support long-term cryo-storage of the cell-gel products.
